Rock Springs Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-152,586
Closed -$4.41M 103
2025
Q4
$4.41M Hold
152,586
0.23% 72
2025
Q3
$1.18M Sell
152,586
-1
-0% -$8 0.07% 83
2025
Q2
$1.13M Hold
152,587
0.07% 84
2025
Q1
$1.31M Buy
152,587
+15,320
+11% +$236K 0.08% 84
2024
Q4
$4.91M Buy
137,267
+15,396
+13% +$796K 0.19% 79
2024
Q3
$5.76M Hold
121,871
0.19% 81
2024
Q2
$6.12M Hold
121,871
0.18% 79
2024
Q1
$13.6M Hold
121,871
0.35% 68
2023
Q4
$7.07M Sell
121,871
-14,254
-10% -$573K 0.17% 79
2023
Q3
$4.32M Hold
136,125
0.12% 86
2023
Q2
$11.2M Sell
136,125
-28,027
-17% -$4.1M 0.27% 74
2023
Q1
$16.9M Hold
164,152
0.4% 64
2022
Q4
$24M Buy
164,152
+1,114
+0.7% +$188K 0.58% 51
2022
Q3
$27.6M Hold
163,038
0.71% 46
2022
Q2
$18.8M Buy
163,038
+12,805
+9% +$1.2M 0.55% 53
2022
Q1
$15M Buy
150,233
+20,275
+16% +$2.37M 0.38% 67
2021
Q4
$20.2M Buy
129,958
+9,130
+8% +$1.78M 0.47% 64
2021
Q3
$28.5M Buy
120,828
+7,003
+6% +$2.05M 0.6% 55
2021
Q2
$38.6M Buy
113,825
+2,820
+3% +$1.07M 0.77% 48
2021
Q1
$44.9M Buy
111,005
+28,458
+34% +$13.8M 0.98% 31
2020
Q4
$54.9M Buy
82,547
+7,130
+9% +$3.96M 1.17% 27
2020
Q3
$35.1M Buy
75,417
+280
+0.4% +$141K 0.89% 37
2020
Q2
$44M Buy
75,137
+25,817
+52% +$8.82M 1.21% 27
2020
Q1
$7.19M Hold
49,320
0.3% 87
2019
Q4
$7.07M Sell
49,320
-6,680
-12% -$488K 0.22% 96
2019
Q3
$2.21M Hold
56,000
0.09% 125
2019
Q2
$5.67M Hold
56,000
0.21% 96
2019
Q1
$7.36M Buy
56,000
+16,000
+40% +$2.01M 0.29% 93
2018
Q4
$4.08M Hold
40,000
0.19% 105
2018
Q3
$10M Hold
40,000
0.36% 86
2018
Q2
$17.9M Sell
40,000
-12,000
-23% -$5.27M 0.69% 48
2018
Q1
$20.5M Sell
52,000
-1,072
-2% -$423K 0.88% 38
2017
Q4
$21.8M Sell
53,072
-128
-0.2% -$55.8K 0.99% 31
2017
Q3
$23M Sell
53,200
-7,916
-13% -$3.12M 1.06% 27
2017
Q2
$21.3M Buy
+61,116
New +$21.1M 1.09% 31

Other funds holding MRSN